Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 25, 2018 | Series B | $80M | 1 | — | — | Detail |
Jun 30, 2016 | Series A | $51.50M | 1 | — | — | Detail |
Jan 1, 2016 | Seed | $3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Schrödinger | — | Series B |